Results 261 to 270 of about 488,841 (318)

Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Folliculotropic mycosis fungoides (FMF) is a rare subtype of MF, characterized by prominent folliculotropism in histopathology. Clinically, FMF exhibits polymorphic presentations, mainly including follicular papules, plaques, alopecia, and other nonspecific lesions, with a predilection for the head and neck region, leading to frequent misdiagnosis ...
Xingyu Li, Jie Liu, Nicola Pimpinelli
wiley   +1 more source

Risk profile of breast cancer following atypical hyperplasia detected through organized screening

, 2015
Elizabeth Buckley, Thomas Sullivan, Gelareh Farshid, Janet E. Hiller, David Roder   +4 more
openalex   +1 more source

Neurogenic Appendicopathy in Pediatric Appendectomies During the COVID‐19 Era: A Retrospective Analysis of Histologically Negative Cases

International Journal of Pediatrics, Volume 2026, Issue 1, 2026.
Introduction In approximately 15% of cases undergoing surgery for acute appendicitis (AA), normal findings are observed in the histological examination of the appendix. Neurogenic appendicopathy (NA) is clinically indistinguishable from AA and is relatively less known.
Yavuz Yilmaz, Elif Emel Erten, Merve Meryem Kiran, Duriye Ozer Turkay, Nikhat Kaura   +4 more
wiley   +1 more source

Clinical and Surgical Evaluation of Sentinel Node Biopsy in Patients with Early-Stage Endometrial Cancer and Atypical Hyperplasia.

Geburtshilfe Frauenheilkd
Pöschke P, Gass P, Krückel A, Keller K, Erber R, Hartmann A, Beckmann MW, Emons J.   +7 more
europepmc   +1 more source

Tyrer–Cuzick Lifetime Risk Is Not Associated With Non‐BRCA1/2 Pathogenic Variants for Breast Carcinoma

The Breast Journal, Volume 2026, Issue 1, 2026.
Background The Tyrer–Cuzick (TC) or IBIS risk calculator is a widely used tool to estimate the probability of developing breast cancer. The latest version incorporates various factors to assess the risk of breast cancer, including family history, personal history, breast density, and past medical history.
Divya Rao, Chloe Wernecke, Lisa Baron, Steven Cai, Peter Beitsch, Rakesh Patel, Pat Whitworth, Barry Rosen, Nhan Nguyen Tran, Kevin Hughes, Paul L. Baron, Imtiaz Wani   +11 more
wiley   +1 more source

Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
ABSTRACT The hormone receptor (HR)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer subtype accounts for most early and metastatic breast cancer (MBC) cases. HR‐positive/HER2‐negative MBC is characterized by a relatively prolonged, although variable, disease course and substantial intertumoral and intratumoral ...
Akshara Singareeka Raghavendra, Senthil Damodaran, Carlos H. Barcenas, Suzanne A. Fuqua, Rachel M. Layman, Debu Tripathy   +5 more
wiley   +1 more source

Evaluation of Sentinel Lymph Nodes in Complex Atypical Endometrial Hyperplasia

Hala Al Kallas, P. H. Cooper, Shruti Varma, J Pepliński, Yan Hong Kuo, Brianna Miller, Noelle Aikman, Mark E. Borowsky, Ashley Haggerty, Karim ElSahwi   +9 more
openalex   +2 more sources

Atypical Endometrial Hyperplasia or Endometrial Cancer in A 65-Year-Old Woman: A Case Report

Lucian Trocadero, Dragoș Brezeanu, Mădălina Boșoteanu, Raluca Ioana Vodă, Vadym Rotar, Paris Ionescu, Ana-Maria Brezeanu   +6 more
openalex   +2 more sources